WAT:NYE-Waters Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 370.98

Change

0.00 (0.00)%

Market Cap

USD 10.92B

Volume

0.18M

Analyst Target

USD 210.31
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Waters Corp is an analytical instrument manufacturer. It designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-01 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+5.03 (+2.19%)

USD 165.08B
A Agilent Technologies Inc

+2.26 (+1.69%)

USD 40.09B
IQV IQVIA Holdings Inc

+2.27 (+1.16%)

USD 36.13B
LH Laboratory Corporation of Amer..

+0.96 (+0.42%)

USD 19.12B
DGX Quest Diagnostics Incorporated

+0.96 (+0.64%)

USD 17.09B
QGEN Qiagen NV

+0.45 (+1.01%)

USD 10.26B
CRL Charles River Laboratories

+3.16 (+1.73%)

USD 9.50B
VNRX Volitionrx Ltd

+0.04 (+6.76%)

USD 0.06B
ENZ Enzo Biochem Inc

+0.02 (+2.21%)

USD 0.04B
MTD Mettler-Toledo International I..

+17.50 (+1.43%)

N/A

ETFs Containing WAT

IVEG iShares Emergent Food and.. 4.56 % 0.00 %

+0.06 (+-0.31%)

USD 4.13M
GSCE:SW BNP Paribas Easy Energy &.. 2.67 % 0.00 %

N/A

USD 0.14B
GSCU:SW BNP Paribas Easy Energy &.. 2.67 % 0.00 %

-0.04 (-0.31%)

USD 0.13B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.52 % 0.00 %

-0.04 (-0.31%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.52 % 0.00 %

-0.02 (-0.31%)

N/A
HLTH:AU VanEck Global Healthcare .. 2.49 % 0.00 %

-0.01 (-0.31%)

USD 0.06B
IBB iShares Biotechnology ETF 2.21 % 0.47 %

+1.24 (+-0.31%)

USD 6.53B
FIW First Trust Water ETF 0.00 % 0.55 %

+0.81 (+-0.31%)

N/A
PHO Invesco Water Resources E.. 0.00 % 0.60 %

+0.50 (+-0.31%)

USD 2.15B
PIO Invesco Global Water ETF 0.00 % 0.75 %

+0.04 (+-0.31%)

USD 0.26B
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

-0.04 (-0.31%)

CAD 0.01B
EMEH:PA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

-0.12 (-0.31%)

USD 0.05B
GSCU:PA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

-0.12 (-0.31%)

USD 0.13B
EMEH:XETRA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

-0.11 (-0.31%)

USD 0.11B
GSDE:XETRA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

-0.22 (-0.31%)

USD 0.47B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 21.28% 100% F 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.28% 100% F 75% C
Trailing 5 Years  
Capital Gain 60.59% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.59% 75% C 74% C
Average Annual (5 Year Horizon)  
Capital Gain 14.21% 85% B 74% C
Dividend Return 14.21% 69% C- 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 33.12% 31% F 32% F
Risk Adjusted Return 42.91% 69% C- 58% F
Market Capitalization 10.92B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.60 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector